Top Abstract Purchase Related
Home
>
Node
>
Subnode

Anticancer effects of Carvone in myeloma cells is mediated through the inhibition of p38 MAPK signalling pathway, apoptosis induction and inhibition of cell invasion

Ding, X.; Chen, H.

Journal of BUON Official Journal of the Balkan Union of Oncology 23(3): 747-751

2018

ISSN/ISBN: 1107-0625
PMID: 30003746
Document Number: 695221
There is accumulating evidence indicating that plant-derived monoterpenes have impressive health-promoting effects, among them anticancer, antimicrobial and many other activities. Carvone is an important monoterpene with pharmacological potential. In the current study we investigated the anticancer effects of carvone in myeloma KMS-5 cells. The cell viability was estimated by MTT assay. Apoptosis was detected by DAPI, acridine orange/ethidium bromide (AO/EB) and annexin V/propidium iodide (PI) staining. Cell cycle analysis was done by flow cytometry. Cell invasion was determined by martigel invasion assay and protein expression was checked by western blotting. The results of the present study indicated carvone exerts significant anticancer effects on the myeloma cancer cells in a dose-dependent manner. The IC50 of carvone was found to be 20 μM against the myeloma KMS-5 cells. The antiproliferative effects were due to induction of apoptosis and G2/M cell cycle arrest. Moreover, carvone could inhibit the cell invasion and the expression of p-P38 protein at IC50. In conclusion, the results indicate that carvone could prove to be an important molecule for the development of natural product-based anticancer therapy, especially against myeloma.

Document emailed within 1 workday
Secure & encrypted payments

Li, Q.; Zhang, J.; Liang, Y.; Mu, W.; Hou, X.; Ma, X.; Cao, Q. 2018: Tanshinone l exhibits anticancer effects in human endometrial carcinoma HEC-1-A cells via mitochondrial mediated apoptosis, cell cycle arrest and inhibition of JAK/STAT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(4): 1092-1096
Li, K.; Yuan, D.; Yan, R.; Meng, L.; Zhang, Y.; Zhu, K. 2018: Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(5): 1420-1425
Lei, X.; Guo, J.; Wang, Y.; Cui, J.; Feng, B.; Su, Y.; Zhao, H.; Yang, W.; Hu, Y. 2019: Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 24(4): 1555-1561
Zhang, X.; Lan, D.; Ning, S.; Ruan, L. 2018: Anticancer action of lactucopicrin in SKMEL-5 human skin cancer cells is mediated via apoptosis induction, G2/M cell cycle arrest and downregulation of m=TOR/PI3K/AKT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(1): 224-228
Ma, X.; Yin, X.; Liu, H.; Chen, Q.; Feng, Y.; Ma, X.; Liu, W. 2019: Antiproliferative activity of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) in human gastric carcinoma cells is facilitated via activation of autophagic pathway, mitochondrial-mediated programmed cell death and inhibition of cell migration and invasion Journal of BUON: Official Journal of the Balkan Union of Oncology 24(5): 2000-2005
Hu, Y.-L.; Wang, X.-B.; Chen, D.-D.; Guo, X.-J.; Yang, Q.-J.; Dong, L.-H.; Cheng, L. 2016: Germanicol induces selective growth inhibitory effects in human colon HCT-116 and HT29 cancer cells through induction of apoptosis, cell cycle arrest and inhibition of cell migration Journal of Buon: Official Journal of the Balkan Union of Oncology 21(3): 626-632
Chen, Y.; Wang, S.; Geng, B.; Yi, Z. 2018: Pelargonidin induces antitumor effects in human osteosarcoma cells via autophagy induction, loss of mitochondrial membrane potential, G2/M cell cycle arrest and downregulation of PI3K/AKT signalling pathway Journal of BUON: Official Journal of the Balkan Union of Oncology 23(3): 735-740
Spanou, D.; Perimenis, P.; Mantzouratou, P.; Gomatos, C.; Cokkinos, D.; Mourouzis, I.; Pantos, C. 2012: Clenbuterol favorably remodels neonatal cardiac cells via activation of p38 MAPK signalling pathway Journal of Cardiovascular Surgery 53(6): 789-795
Huang, A.-C.; Hsu, S.-C.; Kuo, C.-L.; Liao, C.-L.; Lai, K.-C.; Lin, T.-P.; Wu, S.-H.; Lu, H.-F.; Tang, N.-Y.; Yang, J.-S.; Chung, J.-G. 2009: Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF-[kappa]B by the new synthesized ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOTO1007) in human cervical cancer Ca ski cells In Vivo 23(4): 613-619
Hiserodt, J.C.; Bonavida, B. 1981: Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes Journal of Immunology 126(1): 256-262
Touma, R.; Kartarius, S.; Harlozinska, A.; Götz, C.; Montenarh, M. 2006: Growth inhibition and apoptosis induction in ovarian cancer cells International Journal of Oncology 29(2): 481-488
Jiang, Y.; Li, C.; Ma, Y.; Chen, J.; Li, Y.; Chen, L. 2012: The Inhibition of the Pemetrexed-Activated MAPK Pathway via Sorafenib is Involved in the Synergistic Mechanism of Sorafenib Subsequent Potentiation of Pemetrexed Cytotoxicity in EGFR TKI-Resistant Cell Lines Clinical Laboratory 58(5-6): 551-561
Xu, R.; Sato, N.; Yanai, K.; Akiyoshi, T.; Nagai, S.; Wada, J.; Koga, K.; Mibu, R.; Nakamura, M.; Katano, M. 2009: Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells Anticancer Research 29(1): 261-270
Dunn, S.E.; Hardman, R.A.; Kari, F.W.; Barrett, J.C. 1997: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs Cancer Research 57(13): 2687-2693
Zhang, W.; Li, Y.; Luo, J.; Zhao, X.; Xu, J.; Zhu, W.; Jiang, Y.; Fang, F. 2014: Proliferation inhibition and apoptosis induction of Juglone on human cervical cancer Caski cells Wei Sheng Yan Jiu 43(6): 959
Krystal, G.W.; Carlson, P.; Litz, J. 1997: Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins Cancer Research 57(11): 2203-2208
Flynn, V.; Ramanitharan, A.; Moparty, K.; Davis, R.; Sikka, S.; Agrawal, K.C.; Abdel-Mageed, A.B. 2003: Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells International Journal of Oncology 23(2): 317-323
Yurchenko, M.; Shlapatska, L.M.; Romanets, O.L.; Ganshevskiy, D.; Kashuba, E.; Zamoshnikova, A.; Ushenin, Y.V.; Snopok, B.A.; Sidorenko, S.P. 2011: CD150-mediated Akt signalling pathway in normal and malignant B cells Experimental Oncology 33(1): 9-18
Tsuchiya, T.; Tsuno, N.H.; Asakage, M.; Yamada, J.; Yoneyama, S.; Okaji, Y.; Sasaki, S.; Kitayama, J.; Osada, T.; Takahashi, K.; Nagawa, H. 2008: Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells Hepato-Gastroenterology 55(84): 930-935
Kobayashi, H.; Shinohara, H.; Takeuchi, K.; Itoh, M.; Fujie, M.; Saitoh, M.; Terao, T. 1994: Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis Cancer Research 54(3): 844-849